|
eMedonline® is a patented wireless health technology that enables a complete
therapeutic solution for disease management and clinical trials. The system
includes a wireless device along with web-based services that collect and
distribute information between the patient and clinician.
eMedonline automates the collection of compliance data, facilitates outcomes
data entry at the point of care, and enables real time transmission of all
data to a central server with clinical interface. It allows you to map
adherence to outcomes and dosing, and enables predictive modeling and
appropriate intervention to maintain dose intensity.
A medication scheduler notifies patients at programmed intervals and
delivers tailored instructions about the medications being taken based on
the patient profile. Patients take the medication as prescribed, and RFID
or barcode data on the package is read and sent to the server where it is
stored for review, reporting, and modeling. eMedonline automatically
collects time-dose specific data for individual patients— including dosing
times, missed doses, and outcomes data— in real time from a single device.
The data can be analyzed through the eMedonline clinical interface, or
exported for use in other clinical monitoring systems. It provides important
information on the medication status of an individual patient, and on the
patient population as a whole.
eMedonline was developed by Leap of Faith Technologies with support
from the National Cancer Institute for use in clinical trials, and with support
from the National Institute on Aging for use in disease management.
|